Tru Independence Asset Management 2, LLC Pfizer Inc Transaction History

Tru Independence Asset Management 2, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$46.53 - $55.17 $2,000 - $2,372	-43 Reduced 1.0%	4,265 $223,000
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $19,626 - $24,320	-429 Reduced 9.06%	4,308 $223,000
Q4 2021 Jan 20, 2022	BUY	$41.32 - $61.25 $195,732 - $290,141	4,737 New	4,737 $280,000
Q1 2021 May 19, 2021	SELL	$33.49 - $37.77 $90,992 - $102,621	-2,717 Closed	0 $0
Q4 2020 Mar 09, 2021	BUY	$33.47 - $42.56 $90,937 - $115,635	2,717 New	2,717 $100,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Tru Independence Asset Management 2, LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Independence Asset Management 2, LLC with notifications on news.